Jeanne M. Carroll

Jeanne M. Carroll

Auto-generated profile, based on publicly available information

Jeanne M. Carroll

Department of Pediatrics, University of California, San Diego School of Medicine, San Diego, CA, USA

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 April 2019 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
MCMichelle M. Clark
Michelle M. Clark
AHAmber Hildreth
Amber Hildreth
SBSergey Batalov
Sergey Batalov
YDYan Ding
Yan Ding
SCShimul Chowdhury
Shimul Chowdhury
SKStephen F. Kingsmore
Stephen F. Kingsmore
Automated phenotyping and interpretation of rapid whole-genome sequencing improve time to diagnosis of genetic diseases in hospitalized children.

1 June 2021 in Journal of Pediatric Surgery
Verified
Journal Article
Closed access
JPJames M. Prieto
James M. Prieto
MHMatthew T. Harting
Matthew T. Harting
RCRichard Y. Calvo
Richard Y. Calvo
JCJeanne M. Carroll
Jeanne M. Carroll
ASAlicia G. Sykes
Alicia G. Sykes
DLDavid A. Lazar
David A. Lazar

16 May 2014 in Current Protocols in Stem Cell Biology
Verified
Journal Article
Closed access
PDF file
RSRichard S. Song
Richard S. Song
JCJeanne M. Carroll
Jeanne M. Carroll
LALisette Acevedo
Lisette Acevedo
DWDongmei Wu
Dongmei Wu
YLYang Liu
Yang Liu
ESEvan Y. Snyder
Evan Y. Snyder

29 April 2026 in Journal of Perinatology
Verified
Journal Article
Open access
TGTara Glenn
Tara Glenn
JCJeanne Carroll
Jeanne Carroll
AKAmy Kimball
Amy Kimball
MSMark Speziale
Mark Speziale
GRGale Romanowski
Gale Romanowski
LMLaurel Moyer
Laurel Moyer
Objective: Infants in the NICU often require prolonged sedation, increasing risk for iatrogenic withdrawal. We aimed to reduce mean opioid exposure by 20% (26 to 21 days) by May 2023, with sustained improvement through May 2024. Study design: A multidisciplinary team used the Model for Improvement with iterative Plan-Do-Study-Act cycles and EHR tools to implement a standardized sedation-weaning guideline. Applicable outcome, process, and balancing measures were analyzed using statistical process control charts. Results: Among patients receiving >4 days of opioids, mean exposure decreased from 26 to 17 days, length of stay from 70 to 50 days; and overall dexmedetomidine exposure from 18 to 12 days. Adherence to individualized weaning plans improved and feedback indicated effective withdrawal management. Conclusions: Standardized weaning reduced opioid exposure, LOS, and sedative use, enhancing safety, care quality, and NICU capacity.